Evidence map›Paper›PMID 32464116›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Seroprevalence and factors associated with Human Immunodeficiency virus, Human T lymphotropic virus and Hepatitis B/C infections in parturient women of Salvador - Bahia, Brazil.

Ludy Vargas, Fernanda Bastos, André Guimarães, Sávio Amaral, Tarcisio Fausto, Maria Arriaga, Manoel Sarno, Carlos Brites

Open access · goldAbstract read
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. HTLV-1 and Co-infections.Frontiers in medicine · 2022
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Ludy VargasUniversidade Federal da Bahia, Faculdade de Medicina, Salvador, BA, Brazil; Universidad Pedagógica y Tecnológica de Colombia, Boyacá, Colombia. Electronic address: medalexa@hotmail.com.
Fernanda BastosUniversidade Federal da Bahia, Faculdade de Medicina, Salvador, BA, Brazil.
André GuimarãesUniversidade Federal da Bahia, Faculdade de Medicina, Salvador, BA, Brazil.
Sávio AmaralUniversidade Federal da Bahia, Faculdade de Medicina, Salvador, BA, Brazil.
Tarcisio FaustoUniversidade Federal da Bahia, Faculdade de Medicina, Salvador, BA, Brazil.
Maria ArriagaUniversidade Federal da Bahia, Faculdade de Medicina, Salvador, BA, Brazil; Fundação Gonçalo Cruz, Instituto Gonçalo Moniz, Salvador, BA, Brazil; Fundação José Silveira, Instituto Brasileiro para Investigação da Tuberculose, Salvador, BA, Brazil.
Manoel SarnoUniversidade Federal da Bahia, Faculdade de Medicina, Salvador, BA, Brazil; Universidade Federal da Bahia, Maternidade Climério de Oliveira, Salvador, BA, Brazil.
Carlos BritesUniversidade Federal da Bahia, Faculdade de Medicina, Salvador, BA, Brazil; Universidade Federal da Bahia, Faculdade de Medicina, Complexo Hospitalar Prof. Edgard Santos, Salvador, BA Brazil.
Universidade Federal da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe heterogeneity in detection rates of Human immunodeficiency virus, (HIV), Human T lymphotropic virus (HTLV) and Hepatitis B and C infections among pregnant women and the continuous exposure to risk factors limits the adoption of preventive and control actions.

objectiveTo evaluate the HIV, HTLV, Hepatitis B and C seroprevalence rates, and associated risk factors in parturient women in Salvador, Brazil.

methodsThis was a cross-sectional study in 2099 parturient women attended in two public maternity hospitals in Salvador, Brazil. One blood sample was drawn for serological screening and socio-demographic, obstetric and clinical data were collected.

resultsHIV seroprevalence rate was 1.5% (of which 0.6% were new cases); seroprevalence rates for HTLV, HBV, and HCV were 0.4%, 0.4%, and 0.1%, respectively. Univariate analysis showed a significant association between socio-demographic and behavioral factors with retroviral infections, while viral hepatitis was mainly associated with parenteral exposure. In a multivariate analysis, multiple sexual partners (OR 3.3; 95% CI: 1.1-9.2), history of sexual/domestic violence (OR 2.8; 95% CI: 1.1-6.9), syphilis co-infection (OR 2.6; 95% CI: 1.0-6.9), use of alcohol or drugs (OR 2.5; 95% CI: 1.2-5.5), and low schooling level (OR 2.3; 95% CI: 1.1-4.9) were independent risk factors for HIV infection. History of stillbirth and low birth weight infants was significantly associated with HTLV positive status, showing a negative impact on gestation.

conclusionsThe seroprevalence rates for HIV, HCV, HBV, and HTLV were similar to that found in previous studies in other Brazilian regions. The high individual, socioeconomic, and social vulnerability detected in seropositive parturient women indicates the need to improve coverage and effectiveveness of STDs control with prevention, detection and monitoring strategies, focusing in pregnant women exposed to high biopsychosocial risk.

Indexed as

Seroepidemiologic StudiesBrazilCross-Sectional StudiesFemaleHepatitis BHepatitis CHIVHIV InfectionsHTLV-I InfectionsHumansInfantPregnancyRisk FactorsHepatitis BHepatitis CHIVHTLVParturientRisk factorsSeroprevalence

Identifiers

PMID32464116
PMCPMC9392138
OpenAlexW3031741050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.